Replies to post #137272 on NorthWest Biotherapeutics Inc (NWBO)

[Etienne1]

But dilution is nothing for such nwbio's platform with Dcvax-L with glioblastoma that could become second of care and with Dcvax-Direct applicable to many solid tumors. Writing that LP is selling her shares or that she's responsable of dilution (Of course a biotech will finance itself and dilute the shares!, they're not making revenues just yet) is way off.